1. Ionova T.I. Conceptual and methodological aspects the study quality of life in hematology. author. dis. ... doctor. biol. sciences. St. Petersburg, 2009. (in Russian)
2. Gritcay L.N. Quality of life the patients with non-Hodgkin's lymphomas and with acute leukemia. Author. dis. … kand. med. sciences. Novosibirsk, 2007. (in Russian)
3. Loseva M.I., Pospelova T.I., Soldatova G.S., Ageeva T.A., Bondar I.A. et al. Long-term effects of antineoplastic therapy with oncohematological diseases. / Ed. M.I. Loseva. Novosibirsk, 2005. 347p. (in Russian)
4. Novik A.A., Ionova T.I. Guide to the study of quality of life in medicine (3rd ed., revised. and ext.) / Ed. academician Yu Shevchenko. Moscow, 2012. 528 pp. (in Russian)
5. Savchenko V.G. Software treatment of diseases of the blood system: collection diagnostic algorithms and protocols for treatment of diseases of the blood system / Ed. V.G. Savchenko. Moscow, 2012. – 1056 p. (in Russian)
6. ASCO. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines // J. Clin. Oncol. 1996. 14. (3). 671–679.
7. Andrade V., Sawada N.O., Barichello E. Quality of life in hematologic oncology patients undergoing chemotherapy // Rev. Esc. Enferm. USP. 2013. 47. (2). 355–361.
8. Dancey J., Zee B., Osoba D. Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy // Can. Med. Assoc. J. 1996. 10. 225–230.
9. Hwang S.S., Scott C.B., Chang V.T. et al. Prediction of survival for advanced cancer patients by ecursive partitioning analysis: Role of Karnofsky performance status, quality of life, and symptom distress // Cancer Invest. 2004. 22. 678–687.
10. Kim S.H., Kim I.R., Kim S.H., Lee S. Health-related quality of life in Korean lymphoma survivors compared with the general population // Ann. Hematol. 2014. 93. (9). 1531–1540.
11. Jerkeman M., Kaasa S., Hjermstad M. et al. Health-relatedquality of life and its potential prognostic implications in patients with aggressive lymphoma: A Nordic Lymphoma Group Trial // Med. Oncol. 2001. 18. (1). 85–94.
12. Guidelines. Patient-reported outcomes in hematology / Eds. A. Novik, S. Salek, T. Ionova. Genoa: Forum service editore, 2012.
13. Novik A.A., Ionova T.I., Povsun A.S. et al. Early impact of chemotherapy on quality of life of malignant lymphoma patients // Ann. Oncol. 2000. (Suppl. 3). 182.
14. Pulgar A., Alcalá A., Reyes Del Paso G.A. Psychosocial predictors of quality of life in hematological cancer // Behav. Med. 2013. Sep 2. [Epub ahead of print]
15. US Food and Drug Administration: Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Available from U.S. FDA, Clinical Medical, 2009.
16. Uyl-de Groot C.A., Hagnbeek A., Verdonck L.F. et al. Cost-effectiveness of ABMT in comparison with HOP chemotherapy in patients with intermediate and high-grade malignant non-Hogdkins lymphoma (NHL) // Bone Marrow Transplant. 2001. 16. 463–470.
17. Williams G.H. Assessing patients wellness: new perspectives on quality of life and complains // Am. J. Hypertens. 2003. 11. (Pt. 2). 186S–191S.
About Authors (Correspondence):
Gritsay L.N. – candidate of medical sciences, assistant professor of department of therapy, hematology and blood ttransfusion, e-mail: dub_31@mail.ru
Pospelova T.I. – doctor of medical sciences , professor, head of the department of therapy, hematology and blood transfusion, e-mail: postatgem@mail.ru
Nechunaeva I.N. – candidate of medical sciences, head of the department of hematology, e-mail: post_gem@mail.ru
Mishenin A.V. – hematologist of the department of hematology, e-mail: post_gem@mail.ru
